Literature DB >> 3833896

Is conversion of thyroxine to triiodothyronine and reverse triiodothyronine autoregulated? Studies with short term suppression of thyroid function with 3'isopropyl 3,5-diiodothyronine.

R Davies, C Finke, A G Burger.   

Abstract

We investigated the effect of a 6 days course of 20 micrograms of a thyromimetic thyronine analogue 3'isopropyl, 3,5-diiodothyronine (DIIP) on serum thyroid hormone and TSH levels in 10 normal male volunteers. TSH was inhibited progressively during the 6 days of DIIP treatment. By the third day after stopping the treatment this trend had already reversed. Of the serum thyroid hormones the T3 level had decreased by 32% and was the first to increase 5 days after stopping treatment. Serum T4 fell by 35% and returned later to normal. The next effect was an increase in the T3/T4 ratio which was most marked 5 days after treatment had stopped. Kinetic studies with 125I-T3 and 125I-reverse T3 were performed at this time. In comparison to pretreatment kinetics no change in MCR was obtained. It is therefore suggested that at least part of the more rapid increase of T3 than T4 after stopping the suppression therapy reflects an increased conversion.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3833896     DOI: 10.1007/BF03348552

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  8 in total

1.  Letter: (to the editor). Erratum: revised calculations of common parameters of iodothyronine metabolism and distribution by noncompartmental analysis.

Authors:  J H Oppenheimer; H L Schwartz; M I Surks
Journal:  J Clin Endocrinol Metab       Date:  1975-12       Impact factor: 5.958

2.  Labeling of thyroid hormones and their derivatives.

Authors:  A Burger; S H Ingbar
Journal:  Endocrinology       Date:  1974-04       Impact factor: 4.736

3.  The monodeiodination of triiodothyronine and reverse triiodothyronine in man: a quantitative evaluation of the pathway by the use of turnover rate techniques.

Authors:  D Engler; U Merkelbach; G Steiger; A G Burger
Journal:  J Clin Endocrinol Metab       Date:  1984-01       Impact factor: 5.958

4.  Determination of common parameters fo iodothyronine metabolism and distribution in man by noncompartmental analysis.

Authors:  J H Oppenheimer; H L Schwartz; M I Surks
Journal:  J Clin Endocrinol Metab       Date:  1975-08       Impact factor: 5.958

5.  Recovery of serum TSH and thyroid hormones after 3'isopropyl-3,5-diiodo-L-thyronine (DIIP) treatment: absence of inhibiting effect of bromocriptine on TSH secretion and evidence for autoregulation of serum T3 levels.

Authors:  N A Salomon-Montavon; A G Burger
Journal:  J Endocrinol Invest       Date:  1984-10       Impact factor: 4.256

6.  The time course of changes in TRH responsiveness in man following a single dose of liothyronine.

Authors:  F Azizi; A G Vagenakis; S H Ingbar; L E Braverman
Journal:  Metabolism       Date:  1975-06       Impact factor: 8.694

7.  3'-isopropyl-3,5-diiodo-L-thyronine: a potent synthetic thyromimetic thyronine analog. Studies of its kinetics and biological potency in man and rats and its toxicology.

Authors:  C A Kaiser; N A Salomon-Montavon; U Merkelbach; A G Burger
Journal:  J Clin Endocrinol Metab       Date:  1983-07       Impact factor: 5.958

8.  Peripheral tissue mechanism for maintenance of serum triiodothyronine values in a thyroxine-deficient state in man.

Authors:  S M Lum; J T Nicoloff; C A Spencer; E M Kaptein
Journal:  J Clin Invest       Date:  1984-02       Impact factor: 14.808

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.